Summary:Purpose: Antiepileptic drugs (AEDs) may affect serum thyroid hormone concentrations. This study aimed to evaluate thyroid function in men taking carbamazepine (CBZ), oxcarbazepine (OCBZ), or valproate (VPA) for epilepsy.Methods: Ninety men with epilepsy (40 taking CBZ, 29 taking OCBZ, and 21 taking VPA monotherapy) and 25 control subjects participated in the study. After clinical examination, a blood sample for hormone, ␥-glutamyl-transferase (GGT) and antibody (ab) assays was obtained.Results: Serum thyroxine (T 4 ) and free thyroxine (FT 4 ) concentrations were low in men taking CBZ or OCBZ. Forty-five percent of men taking CBZ and 24% of men taking OCBZ had serum T 4 and/or FT 4 levels below the reference range. However, no correlations were found between T 4 or FT 4 and GGT concentrations in men taking CBZ or OCBZ. Thirteen percent of men taking CBZ, 17% of men taking OCBZ, and 6% of control men had increased levels of thyroid peroxidase (TPO)-ab and/or thyroglobulin (TG)-ab, but these were not associated with altered serum thyroid hormone concentrations. Serum triiodothyronine and thyrotropin levels in men taking CBZ or OCBZ were normal. In men taking VPA, the concentrations of thyroid hormones, thyrotropin, and antithyroid ab were normal.Conclusions: Serum thyroid hormone concentrations are low in CBZ-or OCBZ-treated men. However, these low levels do not seem to be due to liver enzyme induction or activation of immunologic mechanisms. Therefore, interference with hypothalamic regulation of thyroid function by CBZ and OCBZ seems possible. VPA does not have any significant effects on thyroid function. Key Words: Epilepsy-Thyroid hormonesCarbamazepine-Oxcarbazepine-Valproate.The endocrine effects of carbamazepine (CBZ) have been well documented. A decrease in serum thyroid hormone levels can already be detected in patients 2 months after starting CBZ (1). However, serum thyrotropin concentrations do not change, and the clinical significance of low serum thyroid hormone concentrations is unclear (1-8). The altered thyroid function during CBZ medication has been attributed to induction of the hepatic P-450 enzyme system and the consequent increase in the metabolism of thyroid hormones (9,10).Oxcarbazepine (OCBZ) is a novel antiepileptic drug (AED) that structurally resembles CBZ. However, the metabolic pathway of OCBZ in the liver is different from that of CBZ. OCBZ is mainly reduced, instead of being oxidized. Consequently, OCBZ does not appear to induce the hepatic P-450 enzyme system (11). Therefore, it has been suggested that OCBZ may not have effects on endocrine function equivalent to those of CBZ, and replacing CBZ with OCBZ resulted in deinduction of liver enzyme levels and short-term restoration of normal endocrine function in men with epilepsy (10,12). However, OCBZ may induce the hepatic P-450 enzyme system when given in high doses, and recent studies have shown that high doses of OCBZ may also affect sex hormone metabolism in men with epilepsy (13). Furthermore, OCBZ is well known to decreas...